Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | ADH1B | P00325 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | ADH4 | P08319 | 1/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1108640 | 0.98 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL15291359 | 0.98 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL23079165 | 0.93 | ALDH1A1 (0.40) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL13066300 | 0.93 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL28017655 | 0.93 | ALDH1A1 (0.40) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL19914450 | 0.91 | ALDH1A1 (0.38) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL19914461 | 0.91 | ALDH1A1 (0.38) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL25811204 | 0.90 | KDM1A (0.31) | — | |
| SCHEMBL27114928 | 0.88 | ALDH1A1 (0.36) | ALDH1A1HSD17B10ADH1BADH1CADH1A | |
| SCHEMBL19825851 | 0.87 | ALDH1A1 (0.44) | ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020150423-A1 | METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | YUMANITY THERAPEUTICS, INC. (US) | 2020-07-23 | — | — | WO | disclosed |